[OS31-3-1] ソラフェニブ、またはソラフェニブ、イリノテカン併用療法を行った小児がん患者の有害事象について
Adverse events in pediatric cancer patients receiving sorafenib or sorafenib plus irinotecan
Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.